Cigarette Smoke Induction of Interleukin-27/WSX-1 Regulates the Differentiation of Th1 and Th17 Cells in a Smoking Mouse Model of Emphysema
Overview
Authors
Affiliations
IFN-γ-producing CD4 T (Th1) cells and IL-17-producing CD4 T (Th17) cells play a critical role in the pathogenesis of chronic obstructive pulmonary disease (COPD). However, the immune regulation between Th1 and Th17 cells remains unclear. Previous studies have demonstrated that interleukin-27 (IL-27)/WSX-1 exerted pro- or anti-inflammatory effects in many acute inflammatory diseases by modulating T cell-mediated immune response, but little was known about its role in chronic inflammatory disease, especially in smoking-related lung diseases. Considering IL-27 is an important regulator in T lymphocytes immune responses and was found markedly increased in patients with COPD, we hypothesized that IL-27/WSX-1 may exert immuno-regulatory effects on the differentiation of Th1 and Th17 cells in smoking-related COPD. In this study, we aimed to evaluate the expression of IL-27 in patients with COPD and explore the role of IL-27/WSX-1 on Th1 and Th17 cells differentiation in a smoking mouse model of emphysema. We found that elevated expression of IL-27 was associated with increased proportion of Th1 cells and Th17 cells in patients with COPD and demonstrated parallel findings in cigarette smoke-exposed mice. In addition, cigarette smoke exposure upregulated the expression of IL-27R (WSX-1) by naive CD4 T cells in mice. , IL-27 significantly augmented the secretion of IFN-γ by naive CD4 T cells a T-bet, p-STAT1, and p-STAT3-dependent manner, but inhibited the production of IL-17 by a ROR-γt and p-STAT1-dependent way. Furthermore, anti-IL27 treatment dramatically decreased the expression of IFN-γ-producing CD4 T cells in cigarette smoke-exposed mice. These findings proposed that IL-27 has functions for promoting the expression of Th1 cells but inhibiting the expression of Th17 cells and IL-27 neutralization-attenuated Th1-mediated inflammation , suggesting targeting IL-27/WSX-1 may provide a new therapeutic approach for smoking-related COPD.
NFIL3/Tim3 axis regulates effector Th1 inflammation in COPD mice.
Ke J, Huang S, He Z, Lei S, Lin S, Li Y Front Immunol. 2024; 15:1482213.
PMID: 39555065 PMC: 11563780. DOI: 10.3389/fimmu.2024.1482213.
Li Q, Wei Y, Wei Y, He K, Liao G, Cheng L J Thorac Dis. 2024; 16(5):3051-3060.
PMID: 38883674 PMC: 11170435. DOI: 10.21037/jtd-23-1647.
Xie G, Huang C, Jiang S, Li H, Gao Y, Zhang T J Orthop Translat. 2024; 46:33-45.
PMID: 38765605 PMC: 11101877. DOI: 10.1016/j.jot.2024.04.003.
Campos G, Americo M, Dos Santos Freitas A, Barroso F, Dutra J, Quaresma L Probiotics Antimicrob Proteins. 2023; 16(2):352-366.
PMID: 36746838 PMC: 9902259. DOI: 10.1007/s12602-023-10041-1.
IL-27 Mediates Pro-Inflammatory Effects the ERK Signaling Pathway During Preterm Labor.
Huang D, Ran Y, Liu Z, He J, Yin N, Qi H Front Immunol. 2021; 12:709229.
PMID: 34691022 PMC: 8531808. DOI: 10.3389/fimmu.2021.709229.